Adjuvant Therapy for Breast Cancer: Recommendations for Management Based on Consensus Review and Recent Clinical Trials

Adjuvant Therapy for Breast Cancer: Recommendations for Management Based on Consensus Review and Recent Clinical Trials Betty A. Mincey, Frances M. Palmieri, Edith A. Perez Oncologist 2002; 7: 246-250. Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in breast cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Learn how evaluation of risk of relapse, results of clinical trials, risk/benefit ratio, and patient preference each contribute to the selection of appropriate adjuvant therapy of breast cancer. Learn important prognostic and predictive factors in the adjuvant therapy of breast cancer. Learn about the roles of local therapy, hormonal treatment, and chemotherapy in the adjuvant therapy of breast cancer. Learn the recommendations of the 2000 NIH Consensus Development Conference: Advances in Breast Cancer. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: June 13, 2002 Most Recent Review: October 13, 2005* Most Recent Update: June 13, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.